Cargando…
Encephalitis following COVID-19 Vaccination: A Systematic Review
Background: Since the advent of global COVID-19 vaccination, several studies reported cases of encephalitis with its various subtypes following COVID-19 vaccinations. In this regard, we conducted a systematic review to investigate and characterize the clinical settings of these reported cases to aid...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054808/ https://www.ncbi.nlm.nih.gov/pubmed/36992160 http://dx.doi.org/10.3390/vaccines11030576 |
_version_ | 1785015760778690560 |
---|---|
author | Abdelhady, Mariam Husain, Muhammad Ashraf Hawas, Yousef Elazb, Mahmoud Abdelsalam Mansour, Lena Said Mohamed, Mohamed Abdelwahab, Maya Magdy Aljabali, Ahmed Negida, Ahmed |
author_facet | Abdelhady, Mariam Husain, Muhammad Ashraf Hawas, Yousef Elazb, Mahmoud Abdelsalam Mansour, Lena Said Mohamed, Mohamed Abdelwahab, Maya Magdy Aljabali, Ahmed Negida, Ahmed |
author_sort | Abdelhady, Mariam |
collection | PubMed |
description | Background: Since the advent of global COVID-19 vaccination, several studies reported cases of encephalitis with its various subtypes following COVID-19 vaccinations. In this regard, we conducted a systematic review to investigate and characterize the clinical settings of these reported cases to aid in physician awareness and proper care provision. Methods: We systematically searched PubMed, Web of Science, and Scopus and manually searched Google Scholar. Studies published until October 2022 were included. Demographic data, clinical features, vaccine data, treatment lines, and outcomes were extracted. Results: A total of 65 patients from 52 studies were included. The mean age of patients was 46.82 ± 19.25 years, 36 cases (55.4%) were males. AstraZeneca was the most-reported vaccine associated with encephalitis (38.5%) followed by Pfizer (33.8%), Moderna (16.9%), and others. Moat encephalitis cases occurred after the first dose of vaccination in 41/65 (66.1%). The mean time between vaccination and symptom onset was 9.97 ± 7.16 days. Corticosteroids (86.2 %) and immunosuppressants (81.5 %) were the most used lines of treatment. The majority of affected individuals experienced a full recovery. Conclusion: Our study summarizes the current evidence of reported post-vaccination encephalitis, regarding clinical presentation, symptoms onset, management, outcomes, and comorbid conditions; however, it fails to either acknowledge the incidence of occurrence or establish a causal relationship between various COVID-19 vaccines and encephalitis. |
format | Online Article Text |
id | pubmed-10054808 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100548082023-03-30 Encephalitis following COVID-19 Vaccination: A Systematic Review Abdelhady, Mariam Husain, Muhammad Ashraf Hawas, Yousef Elazb, Mahmoud Abdelsalam Mansour, Lena Said Mohamed, Mohamed Abdelwahab, Maya Magdy Aljabali, Ahmed Negida, Ahmed Vaccines (Basel) Systematic Review Background: Since the advent of global COVID-19 vaccination, several studies reported cases of encephalitis with its various subtypes following COVID-19 vaccinations. In this regard, we conducted a systematic review to investigate and characterize the clinical settings of these reported cases to aid in physician awareness and proper care provision. Methods: We systematically searched PubMed, Web of Science, and Scopus and manually searched Google Scholar. Studies published until October 2022 were included. Demographic data, clinical features, vaccine data, treatment lines, and outcomes were extracted. Results: A total of 65 patients from 52 studies were included. The mean age of patients was 46.82 ± 19.25 years, 36 cases (55.4%) were males. AstraZeneca was the most-reported vaccine associated with encephalitis (38.5%) followed by Pfizer (33.8%), Moderna (16.9%), and others. Moat encephalitis cases occurred after the first dose of vaccination in 41/65 (66.1%). The mean time between vaccination and symptom onset was 9.97 ± 7.16 days. Corticosteroids (86.2 %) and immunosuppressants (81.5 %) were the most used lines of treatment. The majority of affected individuals experienced a full recovery. Conclusion: Our study summarizes the current evidence of reported post-vaccination encephalitis, regarding clinical presentation, symptoms onset, management, outcomes, and comorbid conditions; however, it fails to either acknowledge the incidence of occurrence or establish a causal relationship between various COVID-19 vaccines and encephalitis. MDPI 2023-03-02 /pmc/articles/PMC10054808/ /pubmed/36992160 http://dx.doi.org/10.3390/vaccines11030576 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Abdelhady, Mariam Husain, Muhammad Ashraf Hawas, Yousef Elazb, Mahmoud Abdelsalam Mansour, Lena Said Mohamed, Mohamed Abdelwahab, Maya Magdy Aljabali, Ahmed Negida, Ahmed Encephalitis following COVID-19 Vaccination: A Systematic Review |
title | Encephalitis following COVID-19 Vaccination: A Systematic Review |
title_full | Encephalitis following COVID-19 Vaccination: A Systematic Review |
title_fullStr | Encephalitis following COVID-19 Vaccination: A Systematic Review |
title_full_unstemmed | Encephalitis following COVID-19 Vaccination: A Systematic Review |
title_short | Encephalitis following COVID-19 Vaccination: A Systematic Review |
title_sort | encephalitis following covid-19 vaccination: a systematic review |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054808/ https://www.ncbi.nlm.nih.gov/pubmed/36992160 http://dx.doi.org/10.3390/vaccines11030576 |
work_keys_str_mv | AT abdelhadymariam encephalitisfollowingcovid19vaccinationasystematicreview AT husainmuhammadashraf encephalitisfollowingcovid19vaccinationasystematicreview AT hawasyousef encephalitisfollowingcovid19vaccinationasystematicreview AT elazbmahmoudabdelsalam encephalitisfollowingcovid19vaccinationasystematicreview AT mansourlenasaid encephalitisfollowingcovid19vaccinationasystematicreview AT mohamedmohamed encephalitisfollowingcovid19vaccinationasystematicreview AT abdelwahabmayamagdy encephalitisfollowingcovid19vaccinationasystematicreview AT aljabaliahmed encephalitisfollowingcovid19vaccinationasystematicreview AT negidaahmed encephalitisfollowingcovid19vaccinationasystematicreview |